HEM Pharma Inc
376270
Company Profile
Business description
HEM Pharma Inc is a microbiome-specialized healthcare company that operates a customized healthcare business and an LBP (Live Biotherapeutic Products) discovery platform business utilizing PMAS (Personalized Pharmaceutical Metal-Analytical Screening), a gut microbiome simulation technology. Its technology includes PMAS, MBR, Multi-omics, Microbiome, and Metabolome.
Contact
558, Handong-ro, Heunghae-eup
F102ho, 102ho
Gyeongsangbuk-do
Buk-gu
Pohang-si
KORT: +82 18994258
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,989.90 | 30.20 | 0.38% |
| CAC 40 | 7,273.12 | 168.32 | 2.37% |
| DAX 40 | 20,954.83 | 580.73 | 2.85% |
| Dow JONES (US) | 40,524.79 | 312.08 | 0.78% |
| FTSE 100 | 8,134.34 | 170.16 | 2.14% |
| HKSE | 21,393.20 | 24.20 | -0.11% |
| NASDAQ | 16,831.48 | 107.03 | 0.64% |
| Nikkei 225 | 34,285.02 | 302.66 | 0.89% |
| NZX 50 Index | 12,073.39 | 34.15 | -0.28% |
| S&P 500 | 5,405.97 | 42.61 | 0.79% |
| S&P/ASX 200 | 7,781.10 | 32.50 | 0.42% |
| SSE Composite Index | 3,253.25 | 9.56 | -0.29% |